Trial Profile
A randomised, double-blind, multicentre, placebo controlled study to evaluate the safety and efficacy of methoxyflurane (PENTHROX) for the treatment of acute pain in children and adolescents from 6 to less than 18 years of age (presenting to an Emergency Department with minor trauma)
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 18 Oct 2023
Price :
$35
*
At a glance
- Drugs Methoxyflurane (Primary)
- Indications Pain
- Focus Registrational; Therapeutic Use
- Acronyms MAGPIE
- Sponsors Medical Developments International
- 18 Oct 2023 This trial has been discontinued in Ireland according to European Clinical Trials Database record.
- 16 Dec 2021 This trial has been completed in Ireland, according to European Clinical Trials Database record.
- 03 May 2021 Planned number of patients changed from 222 to 256.